Unlock instant, AI-driven research and patent intelligence for your innovation.

Rosuvastatin calcium intermediate and method for preparing rosuvastatin calcium intermediate and rosuvastatin calcium

A technology for rosuvastatin and its intermediates, which is applied in the field of organic drug synthesis, can solve the problems of high preparation price, high production cost, and technical difficulty, and achieve the effects of high optical purity, quality improvement, and cost reduction

Inactive Publication Date: 2016-03-02
ZHEJIANG HONGYUAN PHARMA
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] The inventor found by studying the synthetic method of rosuvastatin: according to the method of patent EP0521471A, the starting material of the methyl ester side chain phosphine salt is 3-TBS oxoglutaric anhydride, and chiral benzyl mandelate is used And expensive raw materials such as palladium hydroxide-carbon, the cost is very high, and most of the intermediates are liquid, it is difficult to purify during industrialization, and the technology is very difficult
In addition, we studied the patent EP319847 and found that this method uses ethyl R-4-bromo-3-hydroxybutyrate as the starting material, which is not easy to prepare and has a high initial cost. In addition, the condensation reaction of carbon chain extension Using α-lithium-tert-butyl acetate as raw material, the raw material is deep-frozen, and the preparation price is relatively high. In addition, when the halogen bromine is converted into acetoxy group, the yield is very low, so the final production cost is relatively high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rosuvastatin calcium intermediate and method for preparing rosuvastatin calcium intermediate and rosuvastatin calcium
  • Rosuvastatin calcium intermediate and method for preparing rosuvastatin calcium intermediate and rosuvastatin calcium
  • Rosuvastatin calcium intermediate and method for preparing rosuvastatin calcium intermediate and rosuvastatin calcium

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1: Preparation of 3-hydroxy-5-oxo-hexanoic acid tert-butyl ester

[0034] Add 72g of tert-butyl 3-oxopropionate, 6.1g of tetrahydropyridine, and 300ml of acetone into a 500ml reaction bottle, stir and react at 25-30°C for 2-3 hours, until the raw materials basically disappear as detected by TLC, and desolvate under reduced pressure within 45°C To dryness, 97.7g of compound B was obtained, the purity of which was detected by GC was 91.1%, and the yield was 89.3%.

[0035] The product is yellow liquid. 1HNMR(400MHz, CDCl3)δ4.47–4.35(m,1H),3.48(s,1H),2.65(dd,J=8.3,6.2Hz,2H),2.42(d,J=6.4Hz,2H), 2.19(s,3H),1.44(d,J=5.2Hz,9H).

Embodiment 2

[0036] Example 2: Preparation of 3-hydroxy-5-oxo-hexanoic acid methyl ester

[0037] Add 68g of methyl 3-oxopropionate, 6.1g of tetrahydropyridine, and 300ml of acetone into a 500ml reaction bottle, stir and react at 25-30°C for 2-3 hours, until the raw materials basically disappear as detected by TLC, and precipitate under reduced pressure within 45°C to After drying, 95.7g of compound B' was obtained, the purity of which was detected by GC was 91.5%, and the yield was 89.6%.

Embodiment 3

[0038] Example 3: 6-trans-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)-5-pyrimidine]vinyl-3- Preparation of tert-butyl hydroxy 5-oxopentanoate

[0039] Add 97.7g of compound B and 156.2g of compound C, 580ml of ethanol, 50ml of 5% liquid caustic soda solution into a 1000ml reaction bottle, heat to 25-30°C, stir and react for 3-4 hours, use TLC to detect that the reaction is basically complete, add dilute hydrochloric acid Adjust the pH to neutral, desolvate under reduced pressure to semi-dry within 55°C, add 500ml of ethyl acetate to dissolve, then wash twice with 150ml of water, and desolventize to dryness to obtain 190g of compound D. The purity of HPLC is 93.5%, and the yield is 74.8%. .

[0040] Wherein the NMR data of compound D are:

[0041] 1HNMR (400MHz, CDCl3) δ7.67(m,2H),7.08(m,2H),6.25-6.29(m,1H),5.48-5.54(m,1H),4.47–4.35(m,2H),3.56 (s,3H),3.50(s,3H),δ3.48(s,1H),3.35-3.42(m,1H),2.65(dd,J=8.3,6.2Hz,2H),2.42(d,J =6.4Hz, 2H), 1.44(d, J=5.2Hz, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
optical purityaaaaaaaaaa
Login to View More

Abstract

A rosuvastatin calcium intermediate and a method for preparing the rosuvastatin calcium intermediate and rosuvastatin calcium belong to the technical field of drug organic synthesis. The present invention provides a preparation method of a rosuvastatin intermediate compound D and a rosuvastatin intermediate compound F and a method for preparing rosuvastatin calcium using the compounds. In the present invention, by adopting the above technical means, the total yield of the prepared rosuvastatin calcium is improved, the cost is significantly lowered, and the quality of the rosuvastatin calcium is improved.

Description

technical field [0001] The invention belongs to the technical field of organic synthesis of medicines. Specifically, the invention relates to a rosuvastatin calcium intermediate and a method for preparing the rosuvastatin calcium intermediate and rosuvastatin calcium. Background technique [0002] Rosuvastatin calcium is a new type of inhibitor of HMG-CoA reductase, which can effectively reduce blood lipids. Due to its advantages of high efficiency and low toxicity, it has been widely researched and manufactured. At present, the drug is in the domestic and international markets There are broad prospects. [0003] The compound and its preparation method are disclosed in European patent EP0521471A. The preparation method is characterized in that the pyrimidine core is obtained from polysubstituted formaldehyde, which is condensed with a chiral side chain phosphine salt to obtain the rosuvastatin skeleton through Wittig reaction. Its key synthetic steps are as follows: [00...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/42C12P17/12
CPCC07D239/42C07B2200/07C12P17/12
Inventor 梅光耀金辉牛少凤黄伟平陈军荣缪涵辉郑海成
Owner ZHEJIANG HONGYUAN PHARMA